N-[5-(1-ethylpiperidin-3-yl)-2-[4-[[2-[[2-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-2-oxoethyl]amino]ethylamino]methyl]piperidine-1-carbonyl]-3-pyridinyl]-2-morpholin-4-ylacetamide
C49H64FN11O6 — CID 176581426
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(1-ethylpiperidin-3-yl)-2-[4-[[2-[[2-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-2-oxoethyl]amino]ethylamino]methyl]piperidine-1-carbonyl]-3-pyridinyl]-2-morpholin-4-ylacetamide
N-[5-(1-ethylpiperidin-3-yl)-2-[4-[[2-[[2-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-2-oxoethyl]amino]ethylamino]methyl]piperidine-1-carbonyl]-3-pyridinyl]-2-morpholin-4-ylacetamide (PubChem CID 176581426) has the molecular formula C49H64FN11O6 and a molecular weight of 922.12 g/mol. Its IUPAC name is N-[5-(1-ethylpiperidin-3-yl)-2-[4-[[2-[[2-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-2-oxoethyl]amino]ethylamino]methyl]piperidine-1-carbonyl]-3-pyridinyl]-2-morpholin-4-ylacetamide.
Molecular Properties
| Compound Name | N-[5-(1-ethylpiperidin-3-yl)-2-[4-[[2-[[2-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-2-oxoethyl]amino]ethylamino]methyl]piperidine-1-carbonyl]-3-pyridinyl]-2-morpholin-4-ylacetamide |
|---|---|
| PubChem CID | 176581426 |
| Molecular Formula | C49H64FN11O6 |
| Molecular Weight | 922.12 g/mol |
| Exact Mass | 921.50 |
| IUPAC Name | N-[5-(1-ethylpiperidin-3-yl)-2-[4-[[2-[[2-[4-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]piperazin-1-yl]-2-oxoethyl]amino]ethylamino]methyl]piperidine-1-carbonyl]-3-pyridinyl]-2-morpholin-4-ylacetamide |
| SMILES | CCN1CCCC(c2cnc(C(=O)N3CCC(CNCCNCC(=O)N4CCN(C(=O)c5cc(Cc6n[nH]c(=O)c7ccccc67)ccc5F)CC4)CC3)c(NC(=O)CN3CCOCC3)c2)C1 |
| InChI | InChI=1S/C49H64FN11O6/c1-2-57-15-5-6-36(32-57)37-28-43(54-44(62)33-58-22-24-67-25-23-58)46(53-30-37)49(66)60-16-11-34(12-17-60)29-51-13-14-52-31-45(63)59-18-20-61(21-19-59)48(65)40-26-35(9-10-41(40)50)27-42-38-7-3-4-8-39(38)47(64)56-55-42/h3-4,7-10,26,28,30,34,36,51-52H,2,5-6,11-25,27,29,31-33H2,1H3,(H,54,62)(H,56,64) |
| InChIKey | IILNYQNDOZRAJO-UHFFFAOYSA-N |
| XLogP | 2.53 |
| TPSA | 188.44 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 67 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 922.12 |
| LogP ≤ 5 | 2.53 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176581426 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.